The first course will be overseen by Jodie Hughes, an RCVS and European specialist in anaesthesia and analgesia. The hospital’s inaugural resident will be Luisa Oliveira (pictured right), who earlier completed a rotating internship at North West Veterinary Specialists in Cheshire, and, more recently, an anaesthesia-specific one at NDSR.
Jodie said: “Luisa’s residency will comprise mainly the provision of anaesthesia to multiple animal species, ranging from the ‘simpler’ procedures to the most critical and complex, which we frequently encounter in our interventional cardiac procedures and emergency work.
“A significant component of the training will involve the management of pain, both in the acute setting (in the peri-operative period) and in the chronic setting, whilst dealing with our pain clinic patients.
“Luisa will also be trained in the management of emergency and critical care patients and will undergo rotations in other services to better grasp their requirements.
“As we work exclusively with dogs and cats, we will work in close collaboration with several other hospitals in the UK and continental Europe, to complement Luisa’s training with other species.
“As part of this, Luisa will be exposed to multiple advanced techniques, including ultrasound-guided regional nerve blocks and interventional procedures in our pain clinic.
Luisa said: “This is a fantastic opportunity for me to work alongside an incredibly experienced and skilled team at NDSR.
The training programme has been developed by Rui Pinelas, RCVS and European specialist in anaesthesia and analgesia at NDSR, who is optimistic there will be further training opportunities in the near future.
Rui said: “This was something NDSR has been keen to implement for some time and we had been having ongoing discussions to choose the perfect time.
“In terms of logistics, it took around three months for us to set up this anaesthesia residency, which was largely spent organising our partnerships with the other training facilities and undergoing an evaluation as to whether our facilities and case load would meet the specialist board’s strict requirements, which we are delighted they did.”
For the randomised controlled trial, 528 dairy heifers were monitored for 34 months to investigate the effects of routine treatment with a NSAID at calving and during treatment for lameness, on the future probability of lameness and culling.
The cows were exposed to normal farm conditions and were split into four groups:
During the study, the probability of lameness was assessed by a lameness outcome score collected every 14 days.
Data on culling was also extracted from farm records.
438 animals were included in the final analysis which revealed that treating a cohort of cows following the group three protocol led to an absolute reduction in lameness of approximately 10% and severe lameness of 3%, compared with animals treated in accordance with conventional best practice (group one).
James Wilson BSc(Hons) PhD, foot health consultant and lead researcher on the trial, said: “It appears that through giving heifers a NSAID at critical time points, we have imparted a substantial, long-lasting benefit to them.
"When freshly calved heifers enter the herd for the first time, we understand that they are (typically) naïve to lameness and have good hoof health.
"By utilising NSAIDs strategically, we believe that we have preserved the functionality of the foot, thereby reducing the risk of lameness.
"This is a highly efficacious, cost-effective means of managing lameness on farm.”
Herd Health Consultancy says that in dairy cows, it is advisable to consider using a zero milk-withhold NSAID which is fully licensed to treat lameness in cattle to avoid any need to discard milk, however no NSAID is currently licensed in the UK to treat the pain associated with calving, so careful advice should be given to farmers based on the farm type and production methods.
https://doi.org/10.3168/jds.2021-21329
Reference
The new packaging uses fewer plastic components and a new cardboard box.
Sabrina Jordan, Virbac’s Equine Product Manager said: "The new cardboard component is a substantial step forward making the new packaging more environmentally friendly."
She added: "This new Equimax packaging has a fresh new look and is now available at wholesalers."
The International Task Force on Canine Atopic Dermatitis has published new, evidence-based guidelines for diagnosing, grading and treating Canine Atopic Dermatitis (AD).
Recently published in Veterinary Dermatology, the series of guidelines for general practitioners covers all aspects of the disease, including the recent rise in food allergy-related cases, and offers practical guidance for vets in diagnosing and grading the severity of AD.
The report also reviews the most appropriate treatment options for acute and chronic forms of the disease, and has awarded Cortavance (hydrocortisone aceponate) the best strength of evidence mark of any current treatment available.
Virbac technical director Chris Taylor MRCVS says the paper shows that Cortavance is now the benchmark for Atopic Dermatitis: "Not only do the guidelines confirm evidence of treatment success with Cortavance, but they also highlight that the skin-specific steroid spray has been shown to have no systemic effects, even when applied to one-third of the dog on a daily basis."
Chris also highlights the cost-effectiveness of Cortavance: "Some AD treatments can cost clients more than £2 per day, but with Cortavance owners are usually looking at costs of just pence per day.
"This report shows that not only is Cortavance the most effective treatment with a high safety margin, it is also surprisingly inexpensive too. And of course this should also help with compliance, particularly in uninsured animals."
The guidelines can be viewed or downloaded online free at: http://onlinelibrary.wiley.com/doi/10.1111/j.1365.3164.2010.00889.x/pdf
Vets Now says that the move to holding the 4 day congress online has resulted in a surge in interest from international delegates, with veterinary surgeons and nurses from more than 20 countries, including Kuwait, Hong Kong and Australia, due to attend.
Speakers at the event this year include Dan Fletcher, Megan Brashear and Claire Sharp.
Dan Lewis, Vets Now’s national ECC lead, said: “The interactive platform we’re using is cutting edge and it provides so much more than just webinars. There will be live content, an interactive exhibition hall and more opportunities than ever for delegates to network and learn from some of the world’s leading veterinary experts discussing emergency and critical care.
"Our programme this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
"We’ll obviously miss seeing everyone in person, but we’re very excited that we can gather together online for a one-of-a-kind experience.”
Full four-day tickets for delegates range in price from £60 to £175 and ticket-holders will be able to access all the sessions on-demand for up to a month following the event.
Click here to book your place at Vets Now’s ECC Congress. Registrations close on November 1. To book your place, visit: congress.vets-now.com
The RCVS Officers will be heading to Somerset, home ground of President Bob Moore, on Thursday 22 May for RCVS Question Time.
The Shrubbery Hotel in Ilminster is the venue for the final Regional Question Time of Bob Moore’s Presidential year, where he looks forward to seeing lots of familiar faces for a lively debate.
Veterinary surgeons, veterinary nurses and others involved in the profession are all welcome to attend the meeting, which kicks off at 6:30pm with a relaxing drink, a bite to eat and a chance to catch up with colleagues, followed by Question Time at 7:15pm. The meeting will finish at approximately 10:00pm.
Bob Moore will be chairing the meeting and the panel will be made up of the Officer team and Veterinary Nurses Council Chairman Andrea Jeffery, who will be answering your questions and concerns regarding the veterinary profession.
Hot topics expected to be raised on the night include the RCVS Practice Standards Scheme, a new Veterinary Surgeons Act, RCVS modular certificate, 24-hour cover, the Professional Development Phase and the non-statutory Register for veterinary nurses.
To book your place contact Fiona Clark at the RCVS on 020 7202 0773 or f.clark@rcvs.org.uk before 9 May 2008, or download an invitation at http://www.rcvs.org.uk/ and post it to the address supplied. All veterinary surgeons and veterinary nurses living within reasonable travelling distance of the meeting venue will be sent a personal invitation.
If you are unable to attend the meeting, but have a question you would like to raise, please do write in.
It was the only organisation from the veterinary profession to be shortlisted.
The Antibiotic Guardian Awards were introduced this year by Public Health England (PHE) and aim to champion UK organisations and individuals who have demonstrated achievement in tackling antimicrobial resistance at a local, regional or national level.
BEVA first launched its Protect ME antimicrobial campaign in 2012 to coincide with European Antimicrobial Awareness day. The Association has launched additional resources each year to facilitate compliance and educate the public about the importance of antimicrobial awareness.
Mark Bowen, President of BEVA and co-author of the Protect ME toolkit, said: "It is a great achievement for a veterinary organisation to be recognised alongside the human health sector which invariably has significantly more resources to support antimicrobial stewardship. Protect ME has had a fantastic uptake from the equine profession and are proud of the impact that it is having. BEVA is grateful to all who have contributed to its success, especially Wendy Furness and Jacky Paton of the Scarsdale veterinary group, Derby who trialled it prior to launch and adopted it fully within the practice."
The BEVA Protect ME toolkit is free to BEVA members and can be downloaded at www.beva.org.uk.
The two sets of guidance cover:
RCVS President Dr Mandisa Green said: “I would like to reassure my colleagues once again that we understand the extreme challenges and difficult decisions they are facing.
"The College has no interest in taking anyone to task for considered professional judgement, providing they act reasonably in the circumstances, can justify their actions and take reasonable notes.
"Sadly, we’re seeing the pandemic situation deteriorating again in the UK, but to varying degrees across the country. This presents a significant challenge in ensuring our guidance is clear and straightforward, while remaining relevant to as many people as possible.
"We sincerely hope this new guidance achieves that aim and supports veterinary professionals working to uphold animal health and welfare, while maintaining the safety of their teams and clients."
For more information, visit: https://www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/
The service will be headed by José C. Almansa Ruiz DVM (Hons) MSc (Vet) MRCVS.
José qualified from the Universidad Complutense de Madrid in 2008, before completing an honours degree in dentistry and maxillofacial surgery while working in an after-hours veterinary emergency hospital in Madrid.
In 2009, he relocated to South Africa where he undertook an internship in dentistry and maxillofacial surgery at the academic hospital of the faculty of veterinary science of the University of Pretoria. In 2011, he relocated to the UK and, in 2012, began the European Veterinary Dental College diploma.
In 2015, he returned to South Africa, working in referral hospitals, before being appointed as an extraordinary lecturer in veterinary dentistry and maxillofacial surgery at the Faculty of Veterinary Science of the University of Pretoria in January 2018.
This summer, José will sit the exams to become a European Specialist in Veterinary Dentistry.
Tim Richardson, managing director of both Southfields and Davies, said: “We look forward to welcoming José to the teams at both Southfields and Davies. He brings with him a wealth of experience and knowledge in his field and is a highly-respected clinician.
"The launch of dentistry and maxillofacial services at our multi-disciplinary referral centres is another exciting addition and we’re looking forward to accepting referrals from colleagues across the profession as we continue to lead the industry in the breadth of treatments that we can now offer.”
José said: “I’m delighted to be joining the teams at Southfields and Davies, and my plan is to establish and really grow a dentistry and maxillofacial surgery service over the coming 12 months.
“I would like to start offering reconstruction techniques for those patients undergoing mandibulectomies, while I have been hoping for some time now to begin using 3D printing as part of the planning for big surgeries.
“We will be offering a very complete and advanced veterinary dentistry service. From the maxillofacial surgery point of view, fracture repair procedures will see the introduction of non-invasive techniques for repair of maxillomandibular fractures.
“Craniofacial trauma cases will be worked up more in-depth together with anaesthesia, diagnostic imaging, ophthalmology, critical care and neurology, which will offer a truly multidisciplinary approach.”
For more information, visit www.southfields.co.uk or vetspecialists.co.uk.
Two new edition's of Veterinary Focus, Royal Canin's free journal for companion animal veterinary surgeons are now available free of charge to UK vets.
Focus on Respiratory Disease includes features on brachycephalic syndrome, feline asthma, thoracic radiography of respiratory cases, canine fungal rhinitis, tracheobronchial foreign bodies in dogs and cats, emergency care of patients with acute respiratory distress, and respiratory parasitic diseases. Contributors include representatives from veterinary universities in Germany, Spain, Italy, the USA, and Argentina, and from the UK, Martin Sullivan BVMS, PhD, DVR, Dipl. ECVDI, MRCVS from Glasgow University and Mike Stafford Johnson, MVB, MRCVS, DVC Cert, SAM, MACVS from the Veterinary Cardiorespiratory Centre in Kenilworth.
Focus on Liver Disease includes features on feline inflammatory liver disease, canine portosystemic shunts, jaundice in the dog, extra-hepatic biliary system surgery, laboratory tests for liver disease, liver enzyme testing, diagnosis and treatment of liver tumours, and liver biopsy sampling. Contributors include representatives from veterinary universities in France, Spain, Italy, the USA, New Caledonia, Argentina, and Grenada, and from the Faculty of Veterinary Medicine, University of Edinburgh, Danielle Gunn-Moore, BSc. BVM&S, PhD, FHEA, MACVSc, MRCVS, Nicki Reed, BM&S, Cert VR.DSAM (Feline) Dipl. ECVIM-CA, MRCVS, and Kathryn Pratschke, MVB. MVM, Cert SAS, Dipl. ECVS, MRCVS.
Lee Danks, Royal Canin Veterinary Support manager, said: "Focus is a really interesting and informative publication, and with each issue focusing on a particular body system it offers a complete review of the latest thinking in each area. The contributors are all highly renowned in their individual fields, and being able to provide this kind of expertise to our veterinary partners is something we are really proud of."
Veterinary Focus is published in English, French, German, Chinese, Italian, Polish, Portuguese, Spanish, Japanese, Greek and Russian and reaches over 80,000 veterinary surgeons worldwide.
For a free copy of Focus, speak to your Royal Canin veterinary business manager, who will add you to the subscription list.
Novartis Animal Health has announced that Crovect 1.25% Pour-On solution for sheep, a broad spectrum ectoparasiticide, is now licenced for the treatment of ticks, with a persistent efficacy of ten weeks and the majority killed within three hours.
Crovect also works in the treatment and control of headflies, the treatment of biting lice, and the prevention and treatment of blowfly strike in sheep.
Crovect has a meat withhold period of eight days. Novartis says this makes Crovect the long-lasting tick treatment with the shortest meat withhold period available, which is of use to farmers taking lambs to market at this time of year.
Helen Langham, Brand Manager at Novartis Animal Health said: "Farmers now have another option available for effective and long lasting tick treatment for their flocks, and one that can be flexibly used in lambs to be marketed. This should greatly reduce the worry of tick infestation along with the associated welfare and economic problems, and we are pleased to bring this solution to the market".
Zoetis Business Consulting has announced the launch of Profitsolver, a software tool designed to boost practice profits.
The software has already been rolled out in the US, where Zoetis says that it has delivered an average of £103,000 extra profit to veterinary practices within a year.
Profitsolver uses the practice's actual data - not benchmarks or accepted norms - to enable the practice to manage costs, set prices and gain return on investments. By using an activity-based costing model and using a variety of data such as practice costs, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profitsolver calculates the correct pricing to both cover costs and deliver a predetermined profit margin.
Zoetis says that Profitsolver helps practices to understand how the overall practice profit is being generated. For instance, for price sensitive procedures such as vaccination, the practice can match their prices with the competition, but maintain their profit margin by increasing the price for other clinical services.
Nick Steele, national consulting manager at Zoetis said: "Veterinary practices have no standard method for pricing their services and they are often unable to determine which services make money and which don't. This hampers the practice's ability to accurately value the business and, as a result, profit levels tend to be low for many practices. Profitsolver can turn this situation around and already has a very successful track record in the US."
Zoetis piloted the UK version of Profitsolver with John Goulding at St Georges Veterinary Group. He said: "By and large the veterinary profession still relies on the mark-up of medicines where profits are concerned. Even practices that have made a concerted effort to move away from this type of pricing structure are still making their money from the sale of medicines rather than from vets' fees. For years I have wanted to know exactly how to price our services and this new Profitsolver software does just that.
"Most costs have an element of staff time, an element of fixed assets or equipment and an element of disposable items. Profitsolver takes all of these into account, adds the predetermined profit margin and produces an accurate pricing structure for each procedure undertaken within the practice.
"It's important to take the time at the start to put accurate data in from the practice's latest set of accounts and the Zoetis business consultant will guide practices through this to make the initial set up as easy as possible. For instance, for major pieces of equipment such as X-ray machines, you have to work out how many times a year you are likely to use them.
"By using Profitsolver, we worked out that if we do exactly the same amount of work as last year we can increase our bottom line by at least £200,000 for our 18 vet practice. Since last November, when we installed Profitsolver, we have completely changed our pricing structure moving away from focusing on medicines and the size of the animal to rethink how we charge our clinical care.
"An unexpected benefit is that Profitsolver has made me much more confident about the prices we charge to clients as it is all broken down, so we can see exactly how the invoice is made up. I would be at a loss without it now."
For more information about Profitsolver, contact your Zoetis account manager.
The BSAVA has announced the publication of its latest practical guide: The BSAVA Manual of Canine and Feline Abdominal Surgery.
The new manual covers everything from routine ovariohysterectomy to emergency drainage for acute peritonitis and features two new chapters on laparoscopic instrumentation/surgery and urinary incontinence.
The extensively revised and updated second edition equips veterinary surgeons with practical information, illustrations and images, along with step-by-step operative techniques that provide information on patient positioning and preparation, instrumentation and postoperative management for a variety of procedures.
International expertise includes editors John Williams and Jacqui Niles, as well as contributions from vets around the world.
The BSAVA says that hundreds of veterinary surgeons registered interest in advance after the first edition went out of print last year (2014) and a preview copy was made available at the BSAVA Congress in April.
John Williams said: "The BSAVA exists to promote excellence in small animal practice through education and science, and the BSAVA Manuals are instrumental in fulfilling this aim. As editors of this latest edition, Jacqui and I have had the privilege of being able to work with experts in their respective fields, to produce a practical guide packed full of the latest developments in abdominal surgical techniques that will be useful to the whole veterinary profession."
You can now buy a copy from the BSAVA website: www.bsava.com or by ringing: 01452 726700.
Locum vets Cristiana and Marco Tudini have had the holiday of a lifetime after winning a competition run by the recruitment consultants, Recruit4vets.
The couple, who came to the UK in 2006, were amongst 1000 people who entered the draw last year, when Cristiana was working for Companion Care in Folkestone.
Kelly Worrall from Recruit4vets said: "Our team called Cristiana on a typical day in the practice to deliver the news. She was obviously thrilled to get the call. Not only did we help find Cristiana her dream job, we sent her on a dream holiday too!"
Cristiana said: "My husband and I went to New York at the beginning of December. New York was full of festivities and was magical to go around Christmas time, we even visited Rockefeller Centre and watched the lights and singers. My husband and I are vegan, so we were delighted to find NYC filled with vegan restaurants and fast food outlets, we didn’t stop eating the whole trip!
"New York City was absolutely amazing, this really was a dream come true!"
Ian (pictured right) qualified from Glasgow University and has a master’s degree in veterinary parasitology. He is head of ESCCAP - the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, guideline director for ESCCAP Europe and editorial board member for Companion Animal. and VetCPD Journal. He is also a practising vet and co-owner of The Mount Veterinary Practice in Fleetwood, Lancashire.
Lockdown has seen a rise in the numbers of dogs and cats in the UK, including imported pets. Horiba says some of these are coming in via the official route, which includes preventative measures to reduce health risks. However, many are moved outside of UK regulations and some will become ill in the days or even months after they arrive. Ian will explain how timely, accurate testing will help detect the threat to these animals.
Lisa Martin from Horiba said: "I hope that as many veterinary surgeons, nurses, students and support staff as possible will join us for our Educational Premiere! We are looking forward to this first webinar in our veterinary CPD series, with expert Ian Wright highlighting the best ways to keep pets and people safe. Join us on 1st July at 7.30pm to hear more and to ask Ian your questions on this very topical subject. Dress code: casual."
To register, visit: https://attendee.gotowebinar.com/register/5429203015286962191
In the last four years, there has been an increase in the number of identified B. canis cases in the UK, which had previously been sporadic and isolated.
Data released by the Government shows that cases have risen from three reported before 2020 to 240 in the last three years.
Most dogs were either imported, had returned from holiday overseas, or been bred with an imported dog.
In 2022, the first UK case of dog-to-human transmission was reported, highlighting the risks to those handling and treating infected dogs and raising levels of concern within veterinary teams, although the BVA says the risk is relatively low.
The BVA, SPVS and BVNA joint policy calls on the Government to :
British Veterinary Association President Anna Judson said: “Vets are seriously concerned about the lack of adequate checks for potentially zoonotic diseases entering the country via imported dogs.
"Brucella canis is not currently considered to be widespread in the UK, so a proactive approach with an emphasis on reducing the risk of this and other worrying exotic diseases being brought into the UK is crucial.
“This is important both for the health of the UK’s dogs and the humans who care for them."
https://www.bva.co.uk/take-action/our-policies/brucella-canis
The talk, which is sponsored by Supreme Petfoods, will be co-delivered by Craig Tessyman, who works alongside Molly as Exotics Veterinary Nurse Team Leader at Rutland House Veterinary Referrals.
The presentation will focus on the main aspects of emergency care, including best practice for managing these cases in first opinion practice.
Topics will include restoring and maintaining fluid balance, cardio-pulmonary resuscitation (CPR), analgesia options and the importance of appropriate monitoring.
Molly said: “The basic principles of emergency care apply to all species, but with small herbivores, rapid intervention is crucial as their delicate physiology can quickly spiral into crisis when they become unwell.
"In this session, Craig and I will share practical tips that vets and nurses can implement immediately, without requiring specialist equipment, to help manage these challenging cases.”
The sixty minute talk will start at 12.50pm in the Gallery Suite 3-4.
For those unable to attend the live event, a recorded version of the presentation will be available here: https://supremepetfoods.com/vet-zone/cpd-webinars-and-videos/
Police have advised veterinary practices to be on their guard following a spate of break-ins in the South East, linked to the theft of controlled drugs.
PC Steve Doswell, Controlled Drugs Liaison Officer in the East Sussex police area said: "Criminal elements in the South East are targeting practices in Surrey, Hampshire and East Sussex. They may well have targeted, or will target, other practices in all of the neighbouring counties".
"Methadone, Ketamine, Alprazolam and Diazepam are all commonly-abused by drug users, and nationally there have been a lot of problems with users buying street heroin that has been cut with Alprazolam," he added.
PC Doswell offered the following advice to practices:
More detailed information about the correct storage of controlled drugs can be found in the RCVS Practice Standards Scheme Manual: www.rcvs.org.uk/practicestandards
Free places on Vétoquinol's webinar: 'Chronic Pain in the Geriatric Dog: Decision Making and Risk Management' are going fast, according to the company, and those wishing to attend are being advised to register as soon as possible.
Vétoquinol says that at one point, 200 vets registered in just 3 hours, demonstrating the extent to which vets are finding this to be a challenging topic when it comes to managing their day to day case load.
The webinar takes place at 8.30pm on Wednesday 15th June 2011 and the talk is being delivered by Dr. Jo Murrell, Senior Lecturer in Veterinary Anaesthesia at Bristol Vet School and holder of The European Diploma in Veterinary Anaesthesia and Analgesia. She said: "Decision making can be a complex business when so many factors have to be taken into account. We all see geriatric dogs with painful conditions reasonably frequently and concurrent diseases are common. I will be aiming to describe a way to balance out the risks and benefits, to take into account client's concerns and develop a more logical, rational approach to treatment."
To register for the free webinar go to www.thewebinarvet.com/vetoquinol. Enter the code veto11 to obtain the webinar free of charge.
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
To claim the free product, visit www.daxocox.co.uk/trial and use the stock selector to pick the dose sizes to suit the patients you think Daxocox could help.
Animalcare Marketing Manager James Beaumont explained: “When you consider that recent data shows that up to 20% of dogs over one year of age could have some form of OA1, the scale of problem becomes clear – as does the threat to the welfare of our canine companions from OA pain.
“Owners already giving Daxocox to their OA-affected pets, have seen first-hand how it can significantly improve their quality of life.
"90% said that their dog’s osteoarthritis improved, with 84% reporting that their dog’s quality of life improved from “poor or fair” to “good, very good or excellent.”2
James added: “In a study carried out by Animalare, 88% of owners said that weekly NSAID dosing would be easier to remember, or mean they were less likely to miss a dose or that it would control their dog’s pain more effectively.3
“Used as a first line treatment for OA, Daxocox can provide a solid foundation to long-term pain management that suits vets, dogs and their owners.
"As such, we’re confident that once practices have tried it, it will become their canine OA NSAID of choice.”
For more information, visit www.daxocox.co.uk
References
The British Veterinary Association has welcomed the European Commission's Action Plan on Antimicrobial resistance (AMR), launched yesterday on the eve of European Antibiotic Awareness Day.
The Action Plan sets out 12 actions:
However, the association has expressed concern that the Commission has given only qualified support for new antimicrobials for veterinary use. Carl Padgett, President of the BVA, said: "There is much to be applauded in this action plan. In particular the BVA supports the calls for more and better coordinated research, more responsible use of antimicrobials in human and veterinary medicine, and the development of diagnostic tools to quickly and accurately identify the right drug for the right bug.
"The use of antimicrobials in the treatment and control of animal diseases is essential and the BVA supports the strong messages in this plan. Any option for managing AMR must be firmly rooted in sound scientific assessment of the risk.
"While the report recognises the difficulties that have led to the hampering of research into new antimicrobials for veterinary use, we are concerned that there is only qualified support from the Commission for the development of these new medicines for animal use.
"Research into new antimicrobials should be supported in both human and veterinary medicine. We need to ensure the creation of a more predictable regulatory environment to encourage new products for animals to be brought to the market.
"Finally, while the BVA supports the need for a new regulatory framework any new regulations must not impede the ability of veterinary surgeons to prescribe and dispense medicines according to their clinical judgement."
Meanwhile, Jill Moss of the Bella Moss Foundation added her voice to those calling for responsible use of antibiotics, highlighting recent research from the Royal Veterinary College that has established a clear link between pets with MRSA infection and human hospital-associated MRSA. What is less widely recognised, she says, is that resistant bacteria can be passed from human to animal.
The charity is now calling on health and veterinary professionals to work together to achieve a reduction in resistant infections by raising awareness and promoting the responsible use of antibiotics.